Press

CaaMTech Creates Two New Prodrugs of 4-HO-DiPT

Sep 22 • 2 min read

CaaMTech scientists, in collaboration with the Manke Lab at UMass Dartmouth, recently reported their synthesis and structural characterization of two novel prodrugs of 4-HO-DiPT. The scientists published their research in a paper titled, “The methanol and ethanol solvates of 4-glutarato-N,N-diisopropyltryptamine” in the journal Acta Crystallographica. These are the first crystal structures reported for any 4-substituted DiPT compound,…

Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO® Coverage

Sep 22 • 3 min read

Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp (CSE: DELC | OTCQB: DELCF | FRA: 6X0), has expanded its partnership with the Veterans Administration Community Care Network (VA-CCN) to cover SPRAVATO® treatments at select clinics. The partnership will allow VA-CCN patients experiencing treatment-resistant depression (TRD) to access…

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Sep 22 • 3 min read

Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) has successfully exported psilocybin mushrooms to Psilo Scientific Ltd. in Canada. Psilo Scientific, a wholly owned subsidiary of Filament Health Corp., is an exclusively natural psychedelic drug discovery and extraction company. Psyence received a Health Canada import permit obtained by Psilo Scientific in March 2022. The psilocybin…

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives

Sep 22 • 3 min read

Numinus Wellness Inc. (TSX: NUMI | OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the opening of a new clinic in Montreal that will replace an existing downtown clinic. The new site, in the Plateau neighbourhood, will have expanded capacity to offer ketamine treatments, including a wider assortment of ketamine-assisted…

Universal Ibogaine Announces Kelburn Reopening Date

Sep 22 • 2 min read

Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s research and development clinic, the Kelburn Mental Health and Addiction Recovery Center is scheduled to reopen and commence business operations on October 17, 2022 . “Progress is going remarkably well on the renovations and program development, we have key hires…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435